Evaluating the pharmacokinetics and in vivo
cancer targeting capability of Au nanocages by positron emission tomography imaging, ACS Nano (2012).
Not exact matches
Yan said his lab is working to identify new treatments that could
target the PPM1D genetic mutation and shut down its
cancer - growing
capabilities.
The authors then tested the tumor
targeting capability of iPSC - EPCs labelled with the near - infrared fluorescent dye DiR in two established mouse breast
cancer models.